Valeant Pharmaceuticals International Inc (NYSE:VRX)

18.68
Delayed Data
As of Feb 23
 +0.41 / +2.24%
Today’s Change
8.31
Today|||52-Week Range
24.43
-10.11%
Year-to-Date
Dollar Cost Average on Signet Jewelers
Feb 23 / GuruFocus News - Paid Partner Content
Should You Follow Buffett Into Teva Pharmaceutical?
Feb 20 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close18.27
Today’s open18.39
Day’s range18.21 - 18.84
Volume7,717,779
Average volume (3 months)16,534,516
Market cap$6.5B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-29.57%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)-7.39%
P/E ratio4.8
Price/Sales0.52
Price/Book2.06

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-3.61-3.14%
ACADACADIA Pharmaceutica...+1.28+4.23%
TAROTaro Pharmaceutical ...+0.18+0.18%
----
Data as of 4:01pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)$0.97
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Qubec

Forecasts